Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Scott M. Wasserman
Based on 26 articles published since 2007
||||
Expertise Level
The expertise of Scott M. Wasserman ranks in the
  • Top 0.046%
  • ... of 30,216 published authors worldwide on Hypercholesterolemia
  • ... from 2007 through 2018
  • ... based on contributions to 26 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Thousand Oaks      
2017
  • Amgen Inc, Thousand Oaks, CA, USA. · Current affiliation: AbbVie, North Chicago, IL, USA. · Current affiliation: BioMarin Pharmaceuticals, Novato, CA, USA. · Current affiliation: Quantitative Solutions, a Certara Company, Seattle, WA, USA. · Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town,  South Africa. · Pubmed 27861991
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
2016
  • Amgen Inc., Thousand Oaks, CA. · Amgen Ltd., Uxbridge, United Kingdom. · Pubmed 27707817
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Preventive Cardiology and Rehabilitation, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Wesley Medical Centre, 40 Chasely Street, Auchenflower, Brisbane, 4066, QLD, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Building 65 Missenden Road, Camperdown, NSW, Australia. · Cardiometabolic Disorders, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, Box 1030, New York, NY, 10029, USA. · Amgen (Europe) GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. · Department of Vascular Medicine, F4.211, Academic Medical Center, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. · Pubmed 26936841
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2014
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Wesley Medical Centre, Auchenflower, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Hospital Universitario Miguel Servet, Zaragoza, Spain. · Cardiometabolic Disorders Department, Icahn School of Medicine at Mount Sinai, New York, New York. · Lipid Disorders Clinic, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Hopital Pitie-Salpetriere, Paris, France. · Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, Ohio. · Amgen, Thousand Oaks, California. · Cardiovascular Medicine Department, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24694531
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. Electronic address: · Center for Clinical and Basic Research, Ballerup, Denmark. · Bethesda Health Research Center, Bethesda, Maryland. · Orange County Research Center, Tustin, California. · Amgen Inc., Thousand Oaks, California. · L-MARC Research Center, Louisville, Kentucky. · Pubmed 24691094
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2012
  • Medical Sciences, Amgen, One Amgen Center Drive, Thousand Oaks, California 91320-1799, USA. · Pubmed 23083772
Probable:    University of Cape Town      
2015
  • From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.); Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA (C.S.D., M.L.M., S.M.W., R.S.); Biostatistics-International, Amgen Ltd, Uxbridge, United Kingdom (I.B.); and President, Sterling Research Group, Cincinnati, OH (E.R.). · From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.); Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA (C.S.D., M.L.M., S.M.W., R.S.); Biostatistics-International, Amgen Ltd, Uxbridge, United Kingdom (I.B.); and President, Sterling Research Group, Cincinnati, OH (E.R.). · Pubmed 26228031
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 26 total) written by Scott M. Wasserman about Hypercholesterolemia:

  • Impact of Target-Mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9). 2017
  • Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. 2017
  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. 2017
  • Effect of evolocumab on cholesterol synthesis and absorption. 2016
  • Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. 2016
  • Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. 2016
  • Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study. 2015
  • Evolocumab (AMG 145) for primary hypercholesterolemia. 2015
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
Show List of Full Article Records
Google Searches

Learn more about Scott M. Wasserman using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Thousand Oaks
University of Cape Town
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Thousand Oaks
2017
  • Amgen Inc, Thousand Oaks, CA, USA. · Current affiliation: AbbVie, North Chicago, IL, USA. · Current affiliation: BioMarin Pharmaceuticals, Novato, CA, USA. · Current affiliation: Quantitative Solutions, a Certara Company, Seattle, WA, USA. · Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town,  South Africa. · Pubmed 27861991
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
2016
  • Amgen Inc., Thousand Oaks, CA. · Amgen Ltd., Uxbridge, United Kingdom. · Pubmed 27707817
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Preventive Cardiology and Rehabilitation, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave. Desk JB1, Cleveland, OH, USA. · Wesley Medical Centre, 40 Chasely Street, Auchenflower, Brisbane, 4066, QLD, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Building 65 Missenden Road, Camperdown, NSW, Australia. · Cardiometabolic Disorders, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, Box 1030, New York, NY, 10029, USA. · Amgen (Europe) GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. · Department of Vascular Medicine, F4.211, Academic Medical Center, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. · Pubmed 26936841
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2014
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Wesley Medical Centre, Auchenflower, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Hospital Universitario Miguel Servet, Zaragoza, Spain. · Cardiometabolic Disorders Department, Icahn School of Medicine at Mount Sinai, New York, New York. · Lipid Disorders Clinic, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Hopital Pitie-Salpetriere, Paris, France. · Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, Ohio. · Amgen, Thousand Oaks, California. · Cardiovascular Medicine Department, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24694531
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. Electronic address: · Center for Clinical and Basic Research, Ballerup, Denmark. · Bethesda Health Research Center, Bethesda, Maryland. · Orange County Research Center, Tustin, California. · Amgen Inc., Thousand Oaks, California. · L-MARC Research Center, Louisville, Kentucky. · Pubmed 24691094
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2012
  • Medical Sciences, Amgen, One Amgen Center Drive, Thousand Oaks, California 91320-1799, USA. · Pubmed 23083772
University of Cape Town
2015
  • From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.); Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA (C.S.D., M.L.M., S.M.W., R.S.); Biostatistics-International, Amgen Ltd, Uxbridge, United Kingdom (I.B.); and President, Sterling Research Group, Cincinnati, OH (E.R.). · From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.); Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA (C.S.D., M.L.M., S.M.W., R.S.); Biostatistics-International, Amgen Ltd, Uxbridge, United Kingdom (I.B.); and President, Sterling Research Group, Cincinnati, OH (E.R.). · Pubmed 26228031
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
16 Other Locations Show
Yearly article counts 034482500000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.